secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2023-08-11T23:59:59+00:00
Accession:  0001854270-23-000102
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Bio receives Nasdaq deficiency notice for bid price below $1.00 per share
-------------------------------------------------------------------------------

- Received Nasdaq notice on Aug 7, 2023 for bid price below $1.00 for 30 consecutive days.
- Has 180 days until Feb 5, 2024 to regain compliance with Minimum Bid Price Requirement.
- To regain compliance, closing bid must be at least $1.00 for 10 consecutive trading days.
- Company may consider reverse stock split subject to board and stockholder approval.
- Failure to regain compliance could lead to delisting; may appeal or transfer to Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427023000102/0001854270-23-000102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427023000102/snti-20230807.htm
  HTML page:      https://secwatch.observer/filing/0001854270-23-000102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer